Circulatory Death Donation

The interval after circulatory arrest is critical because organs can sustain ischemic injury when blood flow and oxygen delivery stop. Preservation must therefore begin promptly after clinicians confirm death according to established criteria. Limiting this period helps protect organ viability and supports transplantation for recipients.

The two pathways differ in the condition used to determine death. Circulatory Death Donation proceeds after permanent cessation of circulation and breathing, whether treatment has been withdrawn or an unexpected cardiac arrest occurs. Donation after brain death follows a different death-determination pathway. This distinction affects clinical coordination and the timing of preservation, while both support transplantation.

Independence is an ethical safeguard because it prevents transplantation interests from influencing the determination of death. Clinicians must establish death according to accepted criteria before preservation and donation proceed. This separation protects patient dignity, supports public trust, and ensures that consent governs donation without allowing the prospect of transplantation to shape end-of-life decisions.

In either circumstance, clinicians first apply the established criteria for confirming death. Once death is confirmed, organ preservation begins promptly to reduce ischemic injury. The pathway then depends on coordinated work among critical care, transplant, and donation teams, with informed consent and ethical safeguards maintained throughout. This sequence links clinical care, donation practice, and transplantation.

Coordination is central because donation must connect several time-sensitive activities without confusing their purposes. Critical care, transplant, and donation teams work together around death confirmation, preservation, consent, and transplantation. Effective collaboration helps maintain the required sequence, limits avoidable delay that could worsen ischemic injury, and keeps ethical safeguards visible throughout the process.

The approach may provide kidneys, liver, lungs, and other tissues for people with end-stage organ failure. Its clinical value is therefore both individual and system-wide: recipients may gain access to needed grafts, while donation after circulatory death expands the donor pool beyond donation after brain death.